Patient Referral

Dementia trials are slow and expensive compared to other disease conditions.  Despite the high number of persons developing Alzheimer’s disease each year, on average a clinical trial site only recruits 8-10 participants per year for a particular trial.  Among those referred to a trial, most fail the strict inclusion/exclusion criteria.

Access Free Diagnostic Assessment

By referring your patient to the Australian Dementia Network (ADNeT) Screening for Trials program, your patient will undergo a comprehensive free diagnostic assessment using techniques that are not routinely available, such as PET amyloid and tau brain scans.  With these methods, Alzheimer’s disease can be detected up to 15 years before symptoms become evident (“preclinical AD”).

Results from the assessments are provided to the referring doctor, along with tailored trial recommendations.

We currently have screening sites operating in Melbourne, Adelaide, Sydney, Newcastle, Brisbane, and Perth.

Eligibility Guide

Before referring a patient to the ADNeT Screening for Trials program, please ensure the patient meets all of the following conditions:

  • Probable MCI or mild AD
  • Aged 50 – 80 years
  • Reliable study partner/informant available
  • Minimum MMSE score ≥ 20
  • No serious unstable comorbid conditions

Refer a Patient Now

You can refer your patient to the ADNeT Screening for Trials program by:

  • getting in touch with your local screening locations (click here for more information), or
  • completing the below electronic form below.

Prior Investigations
Please tick if previously completed:
Amyloid PET Feedback
Amyloid PET result to be disclosed by:
Further Investigations
Arrange an expedited brain SPECT & FDG PET if amyloid or tau imaging are negative?
Please provide patient details:
DD slash MM slash YYYY
Drop files here or
Max. file size: 128 MB.

    Download a copy of your local referral form for future use

    Contact Us

    If you have general queries about the ADNeT Screening for Trials program, please: